Teva's O'Grady appointed to Investment Advisory Council.

Byline: Anthony Vecchione

Parsippany-based Teva Pharmaceutical Industries announced the U.S. Department of Commerce selected Brendan O'Grady, executive vice president and head of North America Commercial, to serve on the U.S. Investment Advisory Council.

The Council is a 25-member panel of national experts who will counsel and advise Secretary of Commerce Wilbur Ross on attracting and retaining foreign direct investment in the U.S.

In a press release, Teva said that O'Grady's appointment reflects recognition of his deep expertise spanning more than 28 years in the pharmaceutical industry.

"I am honored to be selected to serve on the Council and provide a unique perspective on the impact and value of foreign direct investment on the pharmaceutical industry in the U.S.," said O'Grady in a statement. "This is especially important as foreign investments can affect domestic innovation for new therapies and help ensure a strong supply chain for safe, effective and lower-cost generic therapies."

...